Jiepei He

C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data

A. Gartland, Ning Wang, Haiping Song, 2022, Cancer communications.

The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer

Abel Bermudez, Sharon J. Pitteri, Karen E. Livermore, 2023, Scientific reports.